Stock listing
PBLS Stock Price, News, Filings & Events — Parabilis Medicines, Inc.
Selected listing: PBLS · NASDAQ · USD · US
This page tracks Parabilis Medicines, Inc.'s PBLS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBLS:NASDAQ. PBLS:NASDAQ is the stock-level entry point for investors researching Parabilis Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Parabilis Medicines, Inc. is a public company traded under the ticker PBLS in the American market. With a market capitalization of approximately $3.49 billion, the company is focused on advancing its innovative therapies. Parabilis is dedicated to improving patient outcomes through its research and development efforts in the biopharmaceutical sector.
- Ticker
- PBLS:NASDAQ
- Asset type
- Stock
- Market cap
- $4.86B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Parabilis Medicines, Inc. PBLS:NASDAQ stock context
This page tracks Parabilis Medicines, Inc.'s PBLS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBLS:NASDAQ. PBLS:NASDAQ is the stock-level entry point for investors researching Parabilis Medicines, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Parabilis Medicines, Inc. is a public company traded under the ticker PBLS in the American market. With a market capitalization of approximately $3.49 billion, the company is focused on advancing its innovative therapies. Parabilis is dedicated to improving patient outcomes through its research and development efforts in the biopharmaceutical sector.
Latest news from Parabilis Medicines, Inc.
Research Parabilis Medicines, Inc.
Parabilis Medicines, Inc. investor report
Review AI stock analysis and investor report context for PBLS:NASDAQ.
Parabilis Medicines, Inc. company profile
View the public company page for Parabilis Medicines, Inc. on 6ix.
Parabilis Medicines, Inc. news
Read company news and market updates connected to Parabilis Medicines, Inc..
Parabilis Medicines, Inc. investor events
Find investor webinars, events, and replay context for Parabilis Medicines, Inc..